A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2009
11/12/2009	US20090281082 Polo-like kinases (Plk1); 1-[1-(2-Chlorophenyl)ethyl]-7-imidazo[1,2-a]pyridin-3-yl-1,2,3,4-tetrahydrothieno[3,2-e][1,4]diazepin-5-one; 3-iodoimidazo[1,2-a]pyridine eractant; ANTITUMOR, ANTIPROLIFERATIVE
11/12/2009	US20090281079 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis
11/12/2009	US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009	US20090281073 Heteroaromatic derivatives useful as anticancer agents
11/12/2009	US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009	US20090281062 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/12/2009	US20090281061 Impaired Alleles of Genes Involved in Metabolic Pathways and Methods for Detecting and Using the Same
11/12/2009	US20090281047 Use of benzaldehyde derivatives, precursors and intermediaries alone or in combination with additional therapeutic agents to stimulate the immune system and inhibit cellular proliferation; e.g. use of 6-0-benzylidine-D-glucopyranosyloxy
11/12/2009	US20090281031 Methods and Compositions Related to Improving Properties of Pharmacological Agents Targeting Nervous System
11/12/2009	US20090281025 Inhibition of tumor growth and metastasis by atf2-derived peptides
11/12/2009	US20090280202 Extracts of Aristolochia Longa pomer and uses thereof
11/12/2009	US20090280194 Use of nitroxyl (hno) for the treatment of cancers overexpressing mat-8
11/12/2009	US20090280166 Ferritin as a therapeutic target in abnormal cells
11/12/2009	US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/12/2009	US20090280133 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
11/12/2009	US20090280127 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-i
11/12/2009	US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
11/12/2009	US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009	US20090280116 Humanized antibodies against tl1a
11/12/2009	US20090280112 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells
11/12/2009	US20090280111 Isolation of the Mitotic Spindle Matrix and its Methods of Use
11/12/2009	US20090280091 5-fluorouracil-resistant bacteria and method for production thereof
11/12/2009	US20090280087 Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer
11/12/2009	US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009	US20090280061 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
11/12/2009	DE102008009039B4 Neue Verbindungen aus Antrodia camphorata New compounds from Antrodia camphorata
11/12/2009	CA2728893A1 Inhibitors of syk protein kinase
11/12/2009	CA2723887A1 Peptide homing to brain tumors
11/12/2009	CA2723716A1 Enhancement of drug therapy by mirna
11/12/2009	CA2723702A1 Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
11/12/2009	CA2723440A1 Sulfobetaines for therapy
11/12/2009	CA2723429A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
11/12/2009	CA2723396A1 Benzene sulfonamide thiazole and oxazole compounds
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	CA2723127A1 Inhibitors of protein kinases
11/12/2009	CA2722992A1 Sequential administration of chemotherapeutic agents for treatment of cancer
11/12/2009	CA2719288A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/11/2009	EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009	EP2116615A1 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
11/11/2009	EP2116596A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
11/11/2009	EP2116543A1 Novel aminopyrimidine derivative as plk1 inhibitor
11/11/2009	EP2116542A1 Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
11/11/2009	EP2116540A1 The salts of 4-aniline quinazoline derivative
11/11/2009	EP2116524A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid
11/11/2009	EP2116523A1 Rexinoid compound having alkoxy group
11/11/2009	EP2116263A1 Reversibly light-switchable drug-conjugates
11/11/2009	EP2116262A2 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
11/11/2009	EP2116259A1 TACI-immunoglobulin fusion proteins
11/11/2009	EP2116254A1 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy
11/11/2009	EP2116248A1 Compositions and Methods of Treatment of Cancer
11/11/2009	EP2116246A1 Composition for treatment of pancreatic cancer
11/11/2009	EP2116241A1 Pharmaceutical composition
11/11/2009	EP2115140A1 Positively charged water-soluble prodrugs of 1h-imidazo [4, 5-c] quinolin-4-amines and related compounds with very high skin penetration rates
11/11/2009	EP2115006A2 Humanized antibodies against cxcr3
11/11/2009	EP2115003A2 Human antibodies to human delta like ligand 4
11/11/2009	EP2114987A1 Foxp3 peptide vaccine
11/11/2009	EP2114982A1 Modulators of hypoxia inducible factor-1 and related uses
11/11/2009	EP2114980A2 Antiviral nucleoside analogs
11/11/2009	EP2114971A1 Fused aromatic ptp-1b inhibitors
11/11/2009	EP2114942A1 Novel aminopyrimidine derivatives as plk1 inhibitors
11/11/2009	EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009	EP2114896A1 Radioprotector compounds and related methods
11/11/2009	EP2114461A2 Diagnostic and therapeutic cyclooxygenase-2 binding ligands
11/11/2009	EP2114454A2 Chemical linkers and cleavable substrates and conjugates thereof
11/11/2009	EP2114442A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
11/11/2009	EP2114414A1 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders
11/11/2009	EP2114397A2 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
11/11/2009	EP2114388A1 Inhibitors of akt activity
11/11/2009	EP1928508B1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
11/11/2009	EP1884240B1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/11/2009	EP1868599B1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors
11/11/2009	EP1818052B1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others
11/11/2009	EP1742937B1 Pyrrolopyrimidine derivatives for treating proliferative diseases
11/11/2009	EP1729808B1 Combination therapy with azd2171 and 5-fu and/or cpt-11
11/11/2009	EP1729807B1 Combination therapy with azd-2171
11/11/2009	EP1713543B1 Use of substituted 1,2,3 indolizine derivatives for treating diseases associated with a pathological angiogenesis
11/11/2009	EP1694331B1 Methods for suppressing an immune response or a treating a proliferating disorder
11/11/2009	EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009	EP1597262B1 Substituted heterocycles
11/11/2009	EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
11/11/2009	EP1519960B1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof
11/11/2009	EP1513551B1 Vaccination with immuno-isolated cells producing an immunomodulator
11/11/2009	EP1492487B1 Mitotic kinesin inhibitors
11/11/2009	EP1490120B1 Embolization
11/11/2009	EP1482795B1 New immunoeffector compounds
11/11/2009	EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
11/11/2009	EP1427418B1 Piperazinone compounds as anti-tumor and anti-cancer agents
11/11/2009	EP1406870B1 Taxol enhancer compounds
11/11/2009	EP1372634B1 Use of fumaric acid amides
11/11/2009	EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
11/11/2009	EP1313734B1 Aza heterocyclic derivatives and their therapeutic use
11/11/2009	EP1278874B1 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/11/2009	EP1158976B1 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/11/2009	CN101578365A Vascular endothelial cell-binding peptide
11/11/2009	CN101578297A Antibody compositions and methods for treatment of neoplastic disease
11/11/2009	CN101578287A Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
11/11/2009	CN101578283A Crystalline forms of thiazolidinedione derivative and its manufacturing method
11/11/2009	CN101578279A Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
11/11/2009	CN101578277A 5-substituted isoindoline compounds
11/11/2009	CN101578275A Anilinopiperazine derivatives and methods of use thereof

1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 2211